Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafal T Olszewski

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Schizophrenia Research|February 4, 2012
mGluR3 and not mGluR2 receptors mediate the efficacy of NAAG peptidase inhibitor in validated model of schizophreniaRafal T Olszewski, Tomasz Bzdega, Joseph H Neale
Psychopharmacology|February 18, 2011
Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophreniaCaterina P Profaci, Kristyn A Krolikowski, Rafal T Olszewski, et al.
Journal of Neurochemistry|January 19, 2006
Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytesBarbara Wroblewska, Iga N Wegorzewska, Tomasz Bzdega, et al.
The Journal of Biological Chemistry|May 10, 2012
Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophreniaDaiying Zuo, Tomasz Bzdega, Rafal T Olszewski, et al.
Trends in Pharmacological Sciences|August 2, 2005
The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophreniaJoseph H Neale, Rafal T Olszewski, Laura M Gehl, et al.
The Laryngoscope|October 17, 2018
Supporting cell survival after cochlear implant surgeryAlvin deTorres, Rafal T Olszewski, Ivan A Lopez, et al.
Molecular Pain|September 14, 2012
NAAG peptidase inhibition in the periaqueductal gray and rostral ventromedial medulla reduces flinching in the formalin model of inflammationToshihiko Yamada, Daiying Zuo, Tatsuo Yamamoto, et al.
Iscience|March 3, 2025
Molecular differences between young and mature stria vascularis from organotypic explants and transcriptomicsMatsya Ruppari Thulasiram, Ryosuke Yamamoto, Rafal T Olszewski, et al.
European Journal of Pharmacology|December 4, 2012
NAAG peptidase inhibitors and deletion of NAAG peptidase gene enhance memory in novel object recognition testKarolina J Janczura, Rafal T Olszewski, Tomasz Bzdega, et al.
The European Journal of Neuroscience|November 9, 2012
Immunohistological and electrophysiological evidence that N-acetylaspartylglutamate is a co-transmitter at the vertebrate neuromuscular junctionKathryn K Walder, Steve B Ryan, Tomasz Bzdega, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Schizophrenia Research|February 4, 2012
mGluR3 and not mGluR2 receptors mediate the efficacy of NAAG peptidase inhibitor in validated model of schizophreniaRafal T Olszewski, Tomasz Bzdega, Joseph H Neale
Psychopharmacology|February 18, 2011
Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophreniaCaterina P Profaci, Kristyn A Krolikowski, Rafal T Olszewski, et al.
Journal of Neurochemistry|January 19, 2006
Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytesBarbara Wroblewska, Iga N Wegorzewska, Tomasz Bzdega, et al.
The Journal of Biological Chemistry|May 10, 2012
Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophreniaDaiying Zuo, Tomasz Bzdega, Rafal T Olszewski, et al.
Trends in Pharmacological Sciences|August 2, 2005
The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophreniaJoseph H Neale, Rafal T Olszewski, Laura M Gehl, et al.
The Laryngoscope|October 17, 2018
Supporting cell survival after cochlear implant surgeryAlvin deTorres, Rafal T Olszewski, Ivan A Lopez, et al.
Molecular Pain|September 14, 2012
NAAG peptidase inhibition in the periaqueductal gray and rostral ventromedial medulla reduces flinching in the formalin model of inflammationToshihiko Yamada, Daiying Zuo, Tatsuo Yamamoto, et al.
Iscience|March 3, 2025
Molecular differences between young and mature stria vascularis from organotypic explants and transcriptomicsMatsya Ruppari Thulasiram, Ryosuke Yamamoto, Rafal T Olszewski, et al.
European Journal of Pharmacology|December 4, 2012
NAAG peptidase inhibitors and deletion of NAAG peptidase gene enhance memory in novel object recognition testKarolina J Janczura, Rafal T Olszewski, Tomasz Bzdega, et al.
The European Journal of Neuroscience|November 9, 2012
Immunohistological and electrophysiological evidence that N-acetylaspartylglutamate is a co-transmitter at the vertebrate neuromuscular junctionKathryn K Walder, Steve B Ryan, Tomasz Bzdega, et al.
Pageof 3